Hydroxychloroquine shortages 'hit patient health'
Up to a quarter of rheumatology patients were disadvantaged in some regions, a global survey suggests
AusDoc brings you the latest news from the American College of Rheumatology virtual congress 2020.
Shortages of hydroxychloroquine and chloroquine early in the COVID-19 pandemic led to 6% of rheumatology patients on the medications being unable to obtain them, which measurably affected their health, a study shows.
Speaking to delegates at the ACR Convergence, the virtual congress of the American College of Rheumatology, Emily Sirotich